-
1
-
-
33745334334
-
Revised diagnostic criteria for neuromyelitis optica
-
Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
-
(2006)
Neurology
, vol.66
, pp. 1485-1489
-
-
Wingerchuk, D.M.1
Lennon, V.A.2
Pittock, S.J.3
-
2
-
-
10344250945
-
A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
-
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
-
(2004)
Lancet
, vol.364
, pp. 2106-2112
-
-
Lennon, V.A.1
Wingerchuk, D.M.2
Kryzer, T.J.3
-
3
-
-
23944444890
-
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
-
Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
-
(2005)
J Exp Med
, vol.202
, pp. 473-477
-
-
Lennon, V.A.1
Kryzer, T.J.2
Pittock, S.J.3
-
4
-
-
0036310181
-
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
-
Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
-
(2002)
Brain
, vol.125
, pp. 1450-1461
-
-
Lucchinetti, C.F.1
Mandler, R.N.2
McGavern, D.3
-
5
-
-
34249711828
-
Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis
-
Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
-
(2007)
Brain
, vol.130
, pp. 1224-1234
-
-
Misu, T.1
Fujihara, K.2
Kakita, A.3
-
6
-
-
77954982900
-
Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study
-
Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010; 75: 208-216.
-
(2010)
Neurology
, vol.75
, pp. 208-216
-
-
Takano, R.1
Misu, T.2
Takahashi, T.3
-
7
-
-
1542395857
-
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
-
Narikawa K, Misu T, Fujihara K, et al. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 2004; 149: 182-186.
-
(2004)
J Neuroimmunol
, vol.149
, pp. 182-186
-
-
Narikawa, K.1
Misu, T.2
Fujihara, K.3
-
8
-
-
78650092261
-
Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6
-
Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010; 16: 1443-1452.
-
(2010)
Mult Scler
, vol.16
, pp. 1443-1452
-
-
Uzawa, A.1
Mori, M.2
Arai, K.3
-
9
-
-
84876337808
-
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis
-
Matsushita T, Tateishi T, Isobe N, et al. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One 2013; 8: e61835.
-
(2013)
PLoS One
, vol.8
-
-
Matsushita, T.1
Tateishi, T.2
Isobe, N.3
-
10
-
-
84879114145
-
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders
-
Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013; 80: 2210-2216.
-
(2013)
Neurology
, vol.80
, pp. 2210-2216
-
-
Sato, D.K.1
Nakashima, I.2
Takahashi, T.3
-
11
-
-
72949114659
-
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
-
Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66: 630-643.
-
(2009)
Ann Neurol
, vol.66
, pp. 630-643
-
-
Bradl, M.1
Misu, T.2
Takahashi, T.3
-
12
-
-
77249090731
-
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
-
Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010; 133: 349-361.
-
(2010)
Brain
, vol.133
, pp. 349-361
-
-
Saadoun, S.1
Waters, P.2
Bell, B.A.3
-
13
-
-
85005784401
-
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
-
Kitic M, Hochmeister S, Wimmer I, et al. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun 2013; 1: 5.
-
(2013)
Acta Neuropathol Commun
, vol.1
, pp. 5
-
-
Kitic, M.1
Hochmeister, S.2
Wimmer, I.3
-
14
-
-
84876144943
-
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
-
Uzawa A, Mori M, Masuda S, et al. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2013; 84: 517-522.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, pp. 517-522
-
-
Uzawa, A.1
Mori, M.2
Masuda, S.3
-
15
-
-
79952762854
-
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
-
Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 2011; 108: 3701-3706.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 3701-3706
-
-
Chihara, N.1
Aranami, T.2
Sato, W.3
-
16
-
-
0031975888
-
Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction
-
Agematsu K, Nagumo H, Oguchi Y, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 1998; 91: 173-180.
-
(1998)
Blood
, vol.91
, pp. 173-180
-
-
Agematsu, K.1
Nagumo, H.2
Oguchi, Y.3
-
17
-
-
72949093353
-
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica
-
Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66: 617-629.
-
(2009)
Ann Neurol
, vol.66
, pp. 617-629
-
-
Bennett, J.L.1
Lam, C.2
Kalluri, S.R.3
-
18
-
-
84892425327
-
Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica
-
Chihara N, Aranami T, Oki S, et al. Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PLoS One 2013; 8: e83036.
-
(2013)
PLoS One
, vol.8
-
-
Chihara, N.1
Aranami, T.2
Oki, S.3
-
19
-
-
84880844455
-
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
-
Araki M, Aranami T, Matsuoka T, et al. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol 2013; 23: 827-831.
-
(2013)
Mod Rheumatol
, vol.23
, pp. 827-831
-
-
Araki, M.1
Aranami, T.2
Matsuoka, T.3
-
20
-
-
84862787794
-
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
-
Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012; 71: 314-322.
-
(2012)
Ann Neurol
, vol.71
, pp. 314-322
-
-
Tradtrantip, L.1
Zhang, H.2
Saadoun, S.3
|